Patent Assignment
Reel/Frame 075821/0655
Change of Name
Recorded: 2026-06-03
Pages: 7
USPTO hasn’t posted the scanned image for this recording yet. Order a certified copy below.
Order Certified Copy
Assignor
FAETH THERAPEUTICS, INC.
Executed: 2026-02-17
Assignee
FAETH THERAPEUTICS, LLC
701 TILLERY STREET #12 #1010, AUSTIN, TEXAS, 78702
Covered Properties
(25)
Benzoxazole Kinase Inhibitors and Methods of Use
Benzoxazole kinase inhibitors and methods of use
Benzoxazole Kinase Inhibitors and Methods of Use
Enhanced Treatment Regimens Using Mtor Inhibitors
Enhanced Treatment Regimens Using mTOR Inhibitors
Formulations for Personalized Methods of Treatment
Application:
63/034,137 →
Formulations for Personalized Methods of Treatment
Formulations for Personalized Methods of Treatment
Application:
19/003,692 →
Publication:
US US20250367169A1
Personalized Methods of Treating Cancer
Application:
63/034,679 →
Personalized Methods of Treating Cancer
Dietary Regimens and Methods for Treatment of Colorectal Cancer
Application:
63/571,720 →
Methods for Modulation of and Sensitization to Serine and Glycine Limitation
Application:
63/126,294 →
Methods for Modulation of and Sensitization to Serine and Glycine Limitation
Application:
63/168,414 →
Methods for Modulation of and Sensitization to Serine and Glycine Limitation
Application:
63/170,805 →
Methods for Modulation of and Sensitization to Serine and Glycine Limitation
Application:
17/551,725 →
Publication:
US US20220193447A1
Personalized Starvation Therapy for Cancer
Application:
63/234,507 →
Personalized Modulation Therapy for Cancer
Application:
63/234,517 →
Personalized Starvation Therapy for Cancer
Application:
63/280,792 →
Personalized Modulation Therapy for Cancer
Application:
18/444,504 →
Publication:
US US20250020651A1
Combination Therapy for PIK3CA-Associated Diseases or Disorders
Application:
63/270,297 →
Combination Therapy for PIK3CA-Associated Diseases or Disorders
Application:
18/638,481 →
Publication:
US US20250082643A1
Personalized Starvation Therapy for Cancer
Application:
63/288,062 →
Personalized Starvation Therapy for Cancer
Application:
18/676,700 →
Publication:
US US20250144067A1
Dietary Regimens and Methods for Treatment of Colorectal Cancer
PCT:
PCT/US2025/022127 ↗
Hpd Inhibitor Compositions and Methods of Use
PCT:
PCT/US2025/021891 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 11, 2009
From: REN, PINGDA; LIU, YI; CHAN, KATRINA; LI, LIANSHENG
To: INTELLIKINE, INC.
Reel/Frame 023502/0150 →
Assignment of Assignor's Interest
Dec 4, 2009
From: REN, PINGDA; LIU, YI; CHAN, KATRINA; LI, LIANSHENG
To: INTELLIKINE, INC.
Reel/Frame 023606/0343 →
Change of Name
Nov 9, 2012
From: INTELLIKINE, INC.
To: INTELLIKINE LLC
Reel/Frame 029276/0179 →
Assignment of Assignor's Interest
Nov 11, 2014
From: LIU, YI; BUI, LYNNE; MARTIN, MICHAEL; WILSON, TROY EDWARD
To: INTELLIKINE LLC
Reel/Frame 034149/0731 →
Assignment of Assignor's Interest
Nov 3, 2015
From: REN, PINGDA; LIU, YI; CHAN, KATRINA; LI, LIANSHENG
To: INTELLIKINE, LLC
Reel/Frame 036948/0579 →
Assignment of Assignor's Interest
Dec 14, 2015
From: LIU, YI; BUI, LYNNE; MARTIN, MICHAEL; WILSON, TROY EDWARD
To: INTELLIKINE LLC
Reel/Frame 037281/0875 →
Assignment of Assignor's Interest
Jun 9, 2020
From: MADDOCKS, OLIVER D.K.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 052876/0485 →
Assignment of Assignor's Interest
Nov 9, 2020
From: MADDOCKS, OLIVER D.K.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 054309/0309 →
Assignment of Assignor's Interest
Jun 23, 2021
From: MADDOCKS, OLIVER D.K.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 056639/0173 →
Assignment of Assignor's Interest
Jun 23, 2021
From: MADDOCKS, OLIVER D.K.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 056639/0156 →
Assignment of Assignor's Interest
Jun 24, 2021
From: INTELLIKINE LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056754/0087 →
Assignment of Assignor's Interest
Sep 28, 2021
From: MADDOCKS, OLIVER D.K.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 057621/0831 →
Assignment of Assignor's Interest
Oct 7, 2021
From: FAETH THERAPEUTICS, INC.
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 057727/0020 →
Assignment of Assignor's Interest
Dec 4, 2021
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: CALITHERA BIOSCIENCES, INC.
Reel/Frame 058288/0933 →
Assignment of Assignor's Interest
Dec 4, 2021
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: CALITHERA BIOSCIENCES, INC.
Reel/Frame 058288/0888 →
Assignment of Assignor's Interest
Dec 14, 2021
From: VOUSDEN, KAREN
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 058383/0235 →
Assignment of Assignor's Interest
Aug 12, 2022
From: MADDOCKS, OLIVER D.K.; YOUNG, TODD; TYRAKIS, PETROS
To: FAETH THERAPEUTICS, INC.
Reel/Frame 060793/0296 →
Assignment of Assignor's Interest
Aug 12, 2022
From: MADDOCKS, OLIVER D.K.; TYRAKIS, PETROS
To: FAETH THERAPEUTICS, INC.
Reel/Frame 060793/0291 →
Assignment of Assignor's Interest
Sep 23, 2022
From: VOUSDEN, KAREN
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 061193/0917 →
Assignment of Assignor's Interest
Sep 23, 2022
From: MADDOCKS, OLIVER D.K.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 061193/0911 →
Assignment of Assignor's Interest
Sep 23, 2022
From: FAETH THERAPEUTICS, INC.
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 061193/0920 →
Assignment of Assignor's Interest
Oct 19, 2022
From: MADDOCKS, OLIVER D.K.; YOUNG, TODD; GONCALVES, MARCUS
To: FAETH THERAPEUTICS, INC.
Reel/Frame 061465/0951 →
Assignment of Assignor's Interest
Nov 16, 2022
From: MADDOCKS, OLIVER D.K.; MISHRA, SWATI
To: FAETH THERAPEUTICS, INC.
Reel/Frame 061802/0792 →
Assignment of Assignor's Interest
Jul 5, 2023
From: CALITHERA BIOSCIENCES, INC.
To: FAETH THERAPEUTICS, INC.
Reel/Frame 064156/0744 →
Assignment of Assignor's Interest
Apr 17, 2024
From: MADDOCKS, OLIVER D.K.; TYRAKIS, PETROS; YOUNG, TODD
To: FAETH THERAPEUTICS, INC.
Reel/Frame 067139/0410 →